CTI Clinical Trial and Consulting Services Announces the Formation of a French Affiliate and Opening of Paris Office
CTI Clinical Trial and Consulting Services (CTI) announces the formation of a new, wholly-owned French subsidiary, CTI Clinical Trial and Consulting Services SARL, and the opening of an office in Paris, France.
“The new company and geographic location continues our expansion throughout Western Europe, which allows us to better serve a growing base of global pharmaceutical and biotechnology companies,” states Patrick Earley, General Manager at CTI. CTI has been working for more than a decade in the drug development industry in North America, Europe, and South America, specializing in clinical research programs involving critically ill patient populations.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
